References
- Herings RM, Klungel OH. An epidemiological approach to assess the economic burden of NSAID induced gastrointestinal events in the Netherlands. Pharmacoeconomics 2001;19:655–65
- Bombardier C, Laine L, Reicin A et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000;343:1520–28
- Silverstein FE, Faich G, Goldstein JL et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. JAMA 2000;284:1247–55
- Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986;256:3358–63
- Anonymous. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum. MMWR 1985;34:185–90
- Mitsuyasu R, Groopman J, Volberding P. Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi’s sarcoma. N Engl J Med 1983;308:1535–6
- Hoigne R. In Dukes MN (Ed): Meyler’s Side Effects of Drugs, 12th edn, 1992. Amsterdam: Elsevier Science, pp.715–28
- Guess HA, Lydick EG, Small RD, Miller LP. Epidemiologic programs for computers and calculators. Exact binominal confidence intervals for the relative risk in follow-up studies with sparsely stratified incidence density data. Am J Epidemiol 1987;125:340–47
- Guess HA, Thomas JE. A rapidly converging algorithm for exact binominal confidence intervals about the relative risk in follow up studies with stratified incidence-density data. Epidemiology 1990;1:75–7
- Bergman U, Boman G, Wiholm B-E. Epidemiology of adverse drug reactions to phenformin and metformin. Br Med 1978;2:464–6
- Borges MS, Capriles-Hulett A, Caballero-Fonseca F, Perez CR. Tolerability to new COX2-inhibitors in NSAID-intolerant patients with cutaneous reactions. Ann Allergy Asthma Immunol 2001;87:201–4
- Patterson R, Bello AE, Lefkowith J. Immunologic tolerability profile of celecoxib. Clin Ther 1999;21:2065–79
- Wiholm B-E, Olsson S, Moore N, Waller P. Spontaneous Reporting Systems Outside the US. In: Strom BL (Ed): Pharmacoepidemiology, 3rd edn, 2000. Chichester: Wiley, pp.175–92
- Roujeau JC, Guillaume JC, Fabre JP et al. Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981–1985. Arch Dermatol 1990;126: 37–42
- Schöpf E, Stuhmer A, Rzany B et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiological study from West Germany. Arch Dermatol 1991;127:839–42
- Chan HL, Stern RS, Arndt KA et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990;126:43–7
- Mockenhaupt M, Schöpf E. Epidemiology of drug-induced severe skin reactions. Semin Cutan Med Surg 1996;15:236–43
- Kaufman DWP, Kelly J, Levy M, Shapiro S. The Drug Etiology of Agranulocytosis and Aplastic Anaemia. 1991, New York: OUP